Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
139M
-
Number of holders
-
259
-
Total 13F shares, excl. options
-
70.1M
-
Shares change
-
-1.08M
-
Total reported value, excl. options
-
$2.31B
-
Value change
-
-$35.8M
-
Put/Call ratio
-
0.78
-
Number of buys
-
116
-
Number of sells
-
-117
-
Price
-
$33.05
Significant Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q3 2022
298 filings reported holding ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") as of Q3 2022.
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) has 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70.1M shares
of 139M outstanding shares and own 50.5% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12.1M shares), VANGUARD GROUP INC (10.1M shares), STATE STREET CORP (5.25M shares), JPMORGAN CHASE & CO (2.89M shares), ALLIANCEBERNSTEIN L.P. (2.47M shares), FMR LLC (2.45M shares), Invesco Ltd. (2.22M shares), GEODE CAPITAL MANAGEMENT, LLC (1.89M shares), CREDIT SUISSE AG/ (1.28M shares), and NORTHERN TRUST CORP (1.28M shares).
This table shows the top 259 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.